<DOC>
	<DOCNO>NCT02259816</DOCNO>
	<brief_summary>Study investigate steady state pharmacokinetics 80 mg telmisartan alone combination repeat dos 10 mg amlodipine</brief_summary>
	<brief_title>Pharmacokinetics Telmisartan Alone Combination With Amlodipine Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>1 . Healthy male female accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( BP , PR ) , 12lead ECG , clinical laboratory test 2 . Age ≥18 Age ≤50 year 3 . BMI ≥18.5 BMI ≤29.9 kg/m2 ( Body Mass Index ) 4 . Signed date write informed consent prior admission study accordance Good Clinical Practice local legislation 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . Surgery gastrointestinal tract ( except appendectomy ) 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 6 . History relevant orthostatic hypotension , faint spell blackouts 7 . Chronic relevant acute infection 8 . History relevant allergy/hypersensitivity ( include allergy drug excipients ) 9 . Intake drug long halflife ( &gt; 24 hour ) within least one month le 10 halflives respective drug prior administration trial 10 . Use drug might reasonably influence result trial prolong QT/corrected QT interval base knowledge time protocol preparation within 10 day prior administration trial 11 . Participation another trial investigational drug within two month prior administration trial 12 . Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) 13 . Inability refrain smoke trial day 14 . Alcohol abuse ( 60 g/day ) 15 . Drug abuse 16 . Blood donation ( 100 mL within four week prior administration trial ) 17 . Excessive physical activity ( within one week prior administration trial ) 18 . Any laboratory value outside reference range clinical relevance 19 . Inability comply dietary regimen trial site 20 . Any history relevant low blood pressure 21 . Supine blood pressure screen systolic &lt; 110 mm Hg and/or diastolic &lt; 60 mm Hg 22 . History urticaria For female subject : 23 . Pregnancy plan become pregnant within 2 month study completion 24 . Positive pregnancy test 25 . No adequate contraception e.g . sterilisation , intrauterine device , use barrier method contraception least 3 month prior participation study 26 . Are willing unable use reliable method barrier contraception ( diaphragm spermicidal cream/jelly condoms spermicidal foam ) , 2 month completion/termination trial 27 . Chronic use oral contraception hormone replacement contain ethinyl estradiol method contraception 28 . Partner unwilling use condom 29 . Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>